Tissue and substrate specificity of inhibition by alkoxy-aryl-lactams of platelet and arterial smooth muscle cyclic nucleotide phosphodiesterases relationship to pharmacological activity-Reference-Cited by-同舟云学术

Tissue and substrate specificity of inhibition by alkoxy-aryl-lactams of platelet and arterial smooth muscle cyclic nucleotide phosphodiesterases relationship to pharmacological activity

Published:1983-06 Issue:3 Volume:113 Page:954-959
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Lugnier Claire,Stierlé Anita,Beretz Alain,Schoeffter Philippe,Lebec Alain,Wermuth Camille-Georges,Cazenave Jean-Pierre,Stoclet Jean-Claude

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference18 articles.

1. Inhibition of cyclic AMP phosphodiesterase activity and myocardial contractility: Effects of cilostamide, a novel PDE inhibitor, and methylisobutylxanthine on rabbit and canine ventricular muscle

2. Human brain and platelet cyclic adenosine 3′,5′-monophosphate phosphodiesterases: Different response to drugs

3. Identification and properties of cyclic nucleotide phosphodiesterases

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Complexity and Multiplicity of the Specific cAMP Phosphodiesterase Family: PDE4, Open New Adapted Therapeutic Approaches;International Journal of Molecular Sciences;2022-09-13

2. Genome-Wide Identification of Candidate Genes for Milk Production Traits in Korean Holstein Cattle;Animals;2021-05-13

3. The long and winding road of designing phosphodiesterase inhibitors for the treatment of heart failure;European Journal of Medicinal Chemistry;2021-02

4. The Endocrine Function of the Heart: Physiology and Involvements of Natriuretic Peptides and Cyclic Nucleotide Phosphodiesterases in Heart Failure;Journal of Clinical Medicine;2019-10-21

5. A comprehensive review on the potential therapeutic benefits of phosphodiesterase inhibitors on cardiovascular diseases;Biomedicine & Pharmacotherapy;2017-10